Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCraneware Regulatory News (CRW)

Share Price Information for Craneware (CRW)

Share Price is delayed by 15 minutes
Get Live Data
1,138.00    28.00 (2.52%)
Bid:
1,138.00
Ask:
1,146.00
Spread: 8.00 (0.703%)
Market Cap: £389.62m
CRW Live PriceLast checked at - London Stock Exchange

Intraday Craneware Share Chart

AGM Statement

17 Nov 2020 07:00

RNS Number : 4950F
Craneware plc
17 November 2020
 

17 November 2020

 

Craneware plc

("Craneware" or the "Company")

 

AGM Statement

 

 

Craneware (AIM: CRW.L), the market leader in Value Cycle software solutions for the US healthcare market, is pleased to provide an update on trading ahead of its Annual General Meeting taking place at 10am today. The AGM will be run as a "closed meeting", with only the minimum required quorum of two shareholders being present as is necessary to enable the formal business of the meeting to be conducted.

 

The first four months of this fiscal year saw a return to strong sales growth, considerably ahead of the equivalent period of the prior year. Results are ahead of management expectations for this stage in the year and, we expect revenues and adjusted EBITDA for the Interim period to 31 December 2020 to be ahead of the equivalent period in the prior year, building the foundation for a return to double-digit growth in the future. We look forward to providing further details within our Trading Update for the 6 months ended 31 December 2020.

 

Our Value Cycle offering, delivered via our cloud-based Trisus platform, continues to resonate with the leadership teams of US hospitals. Trisus provides the means to collect, analyse, compare, verify, and correct their data, so they can improve the financial and operational performance of their hospitals, while improving patient outcomes.

 

With each hospital that joins the platform, Trisus becomes more powerful. Through the recent beta launches of the Trisus (cloud) versions of our core offerings, Chargemaster Toolkit and Pharmacy Chargelink, and our four live Trisus native cloud applications, we now have multiple means by which new and existing customers can join the Trisus Community, providing them with a gateway to the wider benefits the platform can provide.

 

We continue to see substantial new opportunities entering the sales pipeline and the Board is confident in the continued strong performance of the business.

 

 For further information, please contact:

Craneware plc

Peel Hunt 

Investec Bank

Alma

(NOMAD & Joint Broker)

(Joint Broker)

(Financial PR)

+44 (0)131 550 3100

+44 (0)20 7418 8900

+44 (0)20 7597 5970

+44 (0)203 405 0205

Keith Neilson, CEO

Dan Webster

Patrick Robb

Caroline Forde

Craig Preston, CFO

George Sellar

Sebastian Lawrence

Robyn Fisher

Andrew Clark

Henry Reast

Helena BogleJoe Pederzolli

About Craneware

 

Craneware (AIM: CRW.L), the leader in automated value cycle solutions, collaborates with U.S. healthcare providers to plan, execute and monitor value-based economic performance. Founded in 1999, Craneware is headquartered in Edinburgh, Scotland with offices in Atlanta and Pittsburgh employing over 350 staff. Craneware's value cycle management suite includes charge capture, strategic pricing, patient engagement, claims analytics, revenue recovery and retention, and cost and margin intelligence solutions.

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
AGMBIBDBLGBDGGL
Date   Source Headline
1st Jul 20192:00 pmRNSPrice Monitoring Extension
28th Jun 20199:05 amRNSSecond Price Monitoring Extn
28th Jun 20199:00 amRNSPrice Monitoring Extension
28th Jun 20197:00 amRNSTrading Update and Notice of Results
15th Apr 20197:00 amRNSBlock listing Interim Review
15th Mar 20192:50 pmRNSDividend Currency Election
5th Mar 20197:00 amRNSHalf-year Report
21st Dec 20187:00 amRNSTrading Update and Notice of Results
15th Nov 20187:00 amRNSHolding(s) in Company
9th Nov 20188:55 amRNSDividend Currency Election
7th Nov 201810:42 amRNSResult of AGM
6th Nov 20187:00 amRNSAGM Statement and Capital Markets Day
16th Oct 20187:00 amRNSBlock listing Interim Review
11th Oct 201810:50 amRNSPosting of Annual Report and Notice of AGM
5th Oct 20184:39 pmRNSTotal Voting Rights
5th Oct 20182:55 pmRNSHolding(s) in Company
18th Sep 20182:06 pmRNSSecond Price Monitoring Extn
18th Sep 20182:00 pmRNSPrice Monitoring Extension
11th Sep 201811:10 amRNSHolding(s) in Company
10th Sep 20187:00 amRNSDirector/PDMR Shareholding
7th Sep 201811:40 amRNSHolding(s) in Company
5th Sep 201812:20 pmRNSGrant of Options & Long Term Incentive Plan Awards
4th Sep 20187:00 amRNSFinal Results
1st Aug 20187:00 amRNSAppointment of Joint Broker
10th Jul 20187:00 amRNSTrading Update and Significant Contract Win
17th Apr 20181:55 pmRNSBlock listing Interim Review
12th Apr 20189:54 amRNSHolding(s) in Company
6th Apr 20183:10 pmRNSDividend Currency Election
27th Mar 20181:52 pmRNSHolding(s) in Company
19th Mar 20187:00 amRNSDirector/PDMR Shareholding and Total Voting Rights
14th Mar 20182:11 pmRNSAdditional Listing - Blocklisting of Securities
8th Mar 20187:00 amRNSDirector/PDMR Shareholding
6th Mar 20187:00 amRNSHalf-year Report
16th Feb 201811:53 amRNSHolding(s) in Company
13th Feb 20187:00 amRNSSignificant Contract Wins
31st Jan 20182:59 pmRNSTotal Voting Rights
26th Jan 20182:49 pmRNSHolding(s) in Company
26th Jan 201812:10 pmRNSTotal Voting Rights and Director/PDMR Shareholding
23rd Jan 201812:05 pmRNSResult of Share Buyback
17th Jan 20185:59 pmRNSGrant of Options & Long Term Incentive Plan Awards
16th Jan 20187:00 amRNSShare Buyback
8th Jan 20187:00 amRNSTrading Update and Significant Contract Win
29th Nov 20177:00 amRNSHolding(s) in Company
10th Nov 20171:43 pmRNSDividend Currency Election
8th Nov 20175:00 pmRNSResult of AGM
8th Nov 20177:00 amRNSAGM Statement
31st Oct 20177:00 amRNSSignificant Contract Win
27th Oct 20172:07 pmRNSHolding(s) in Company
18th Oct 20172:06 pmRNSBlock listing Interim Review
12th Oct 201712:15 pmRNSPosting of Annual Report and Notice of AGM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.